Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban
Takla R Anis, Whitney Jandreau Pharmacy Department, Northern Light Eastern Maine Medical Center, Bangor, ME, USACorrespondence: Takla R AnisPharmacy Department, Northern Light Eastern Maine Medical Center, 489 State Street, Bangor, ME, 04401, USAEmail takla.anis@gmail.comAbstract: Direct oral antico...
Guardado en:
Autores principales: | Anis TR, Jandreau W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c06e393369324cfda8d742ffaee710fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
por: Jana Úlehlová, et al.
Publicado: (2021) -
Nuevos anticoagulantes orales en la prevención del ataque cerebrovascular
por: Soto V,Álvaro, et al.
Publicado: (2012) -
Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
por: Fabienne Lucas, et al.
Publicado: (2021) -
An itchy rash in a young Caucasian woman
por: Constanze Jonak, et al.
Publicado: (2012) -
Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
por: Chen Luyue, et al.
Publicado: (2021)